Seattle Genetics expects to raise $155 million from offering
This article was originally published in Scrip
Executive Summary
Seattle Genetics has announced that it will sell 10 million shares priced at $15.50 in an effort to raise $155 million. The follow-on offering was underwritten by Jeffries & Co, JP Morgan, Leerink Swann, RBC Capital Markets, Needham, William Blair, Oppenheimer and ThinkEquity.